Showing results (571-580 of 1,011) with videos related to
Sort By:
Pageof 102
Hypertension Research : Official Journal of the Japanese Society of Hypertension|October 13, 2022
Reduced efficacy of blood pressure lowering drugs in the presence of diabetes mellitus-results from the TRIUMPH randomised controlled trialSonali R Gnanenthiran, Ruth Webster, Asita de Silva, et al.European Journal of Preventive Cardiology|October 6, 2012
Use of a Multidrug Pill In Reducing cardiovascular Events (UMPIRE): rationale and design of a randomised controlled trial of a cardiovascular preventive polypill-based strategy in India and EuropeSimon Thom, Jane Field, Neil Poulter, et al.Journal of the American College of Cardiology|March 4, 2026
Preferences for Antihypertensive Prescribing in Older Adults: A Discrete Choice ExperimentEdel O'Hagan, Ann Livingstone, Thomas Gadsden, et al.Diabetes Care|May 10, 2014
Impact of visit-to-visit glycemic variability on the risks of macrovascular and microvascular events and all-cause mortality in type 2 diabetes: the ADVANCE trialYoichiro Hirakawa, Hisatomi Arima, Sophia Zoungas, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 20, 2013
The association of high-density lipoprotein cholesterol with cancer incidence in type II diabetes: a case of reverse causality?Jamie Morton, Martin K C Ng, John Chalmers, et al.Journal of the American Heart Association|July 2, 2018
Relationship Between Plasma 8-OH-Deoxyguanosine and Cardiovascular Disease and Survival in Type 2 Diabetes Mellitus: Results From the ADVANCE TrialMerlin C Thomas, Mark Woodward, Qiang Li, et al.Neurosurgery|June 13, 2017
Practice Patterns for Neurosurgical Utilization and Outcome in Acute Intracerebral Hemorrhage: Intensive Blood Pressure Reduction in Acute Cerebral Hemorrhage Trials 1 and 2 StudiesRui Guo, David J Blacker, Xia Wang, et al.Journal of Cardiac Failure|April 13, 2024
Natriuretic Peptides and Prognosis in Patients With Type 2 Diabetes Mellitus and High Risk for Cardiovascular EventsMuhammad Shahzeb Khan, James L Januzzi, Yuxi Liu, et al.Diabetologia|May 10, 2020
Plasma fatty acids and the risk of vascular disease and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE studyKatie Harris, Megumi Oshima, Naveed Sattar, et al.Diabetes|November 14, 2013
Circulating inflammatory markers and the risk of vascular complications and mortality in people with type 2 diabetes and cardiovascular disease or risk factors: the ADVANCE studyGordon Lowe, Mark Woodward, Graham Hillis, et al.Pageof 102